Keyphrases
Nasopharyngeal Carcinoma
100%
Carcinoma Progression
100%
Fibroblasts
100%
Fibrosis
100%
Yes-associated Protein 1 (YAP1)
100%
Viral
100%
Exosomes
100%
Epstein-Barr
100%
Epstein-Barr Virus
55%
Fibrotic Response
55%
Nasopharyngeal Carcinoma Cells
22%
Tumor Growth
22%
Immunohistochemical Analysis
22%
Metastasis
22%
T Cells
22%
YAP1 Signaling
22%
Immunosuppressive Cytokines
22%
Microenvironment
11%
Human Nasopharyngeal Carcinoma
11%
Latent Membrane Protein 1 (LMP1)
11%
Between-group
11%
RNA Sequencing (RNA-seq)
11%
Multivariate Cox Regression
11%
Cox Regression Model
11%
Log-rank Test
11%
Time-based
11%
Stromal Cells
11%
Xenograft
11%
Mechanistic Studies
11%
Mouse Xenograft Model
11%
Immunostaining
11%
Overall Survival
11%
Immune Response
11%
Chemokine (C-C motif) Ligand 2 (CCL2)
11%
Recurrence-free Survival
11%
Cancer-associated Fibroblasts
11%
Contractility
11%
Survival Time
11%
Independent Prognostic Factor
11%
Culture Supernatant
11%
Co-culture System
11%
Xenograft Model
11%
Tumor Stroma
11%
Intercommunication
11%
Clinical Correlation
11%
Exosomal Cargo
11%
Immune Correlation
11%
Gel Contraction Assay
11%
Spheroid Culture
11%
Granzyme B
11%
Immunohistochemical Assessment
11%
Metastasis-free Survival
11%
Nasopharyngeal Sample
11%
Epstein-Barr Virus Infections
11%
Tumor Spheroids
11%
Multicellular Tumor Spheroids
11%
Kaplan-Meier Survival
11%
Epstein-Barr Virus-positive
11%
T Cell Cytotoxicity
11%
Fibroblast Activation
11%
Real-time Impedance
11%
Tumor Fibrosis
11%
EdU Incorporation
11%
Medicine and Dentistry
Nasopharynx Carcinoma
100%
Exosome
100%
Fibrosis
100%
Fibroblast
100%
Epstein Barr Virus
50%
Xenograft
25%
Immunosuppressive Drug
25%
Carcinoma Cell
16%
Tumor Progression
16%
Neoplasm
16%
Metastatic Carcinoma
16%
Cytokine
16%
Biopsy Technique
16%
Tumor Spheroid
16%
T Lymphocyte
16%
Stroma
16%
Malignant Neoplasm
8%
Latent Membrane Protein 1
8%
Recurrence Free Survival
8%
Proportional Hazards Model
8%
Log Rank Test
8%
Stromal Cell
8%
Immunohistochemistry
8%
RNA Sequence
8%
Immune Response
8%
Prognostic Factor
8%
Overall Survival
8%
Enzyme Linked Immunosorbent Assay
8%
Survival Time
8%
Muscle Contractility
8%
Metastasis Free Survival
8%
Granzyme B
8%
T Cell-Mediated Cytotoxicity
8%
Contraction Assay
8%
Cancer Associated Fibroblast
8%
Epstein-Barr Virus Infection
8%
Immunology and Microbiology
Exosome
100%
Fibroblast
100%
Epstein Barr Virus
77%
Xenograft
33%
Immunosuppressive Drug
33%
Carcinoma Cell
22%
Cytokine
22%
T Cell
22%
Tumor Spheroid
22%
Stroma
22%
Epstein-Barr Virus Latent Membrane Protein 1
11%
RNA Sequence
11%
ELISA
11%
Viral Disease
11%
Coculture
11%
Immune Response
11%
Recurrence Free Survival
11%
CCL2
11%
Muscle Contractility
11%
Overall Survival
11%
Supernatant
11%
Immunostaining
11%
Survival Time
11%
Cancer Associated Fibroblast
11%
T Cell-Mediated Cytotoxicity
11%
Metastasis Free Survival
11%
Granzyme B
11%
Biochemistry, Genetics and Molecular Biology
YAP1
100%
Fibroblast
100%
Epstein Barr Virus
63%
T Cell
27%
Tumor Progression
18%
Cytokine
18%
Tumor Spheroid
18%
Epstein-Barr Virus Latent Membrane Protein 1
9%
Stromal Cell
9%
RNA Sequence
9%
Recurrence Free Survival
9%
Coculture
9%
Immunostaining
9%
Overall Survival
9%
Survival Time
9%
CCL2
9%
Muscle Contractility
9%
Immune Response
9%
Metastasis Free Survival
9%
Cell Mediated Cytotoxicity
9%
Supernatant
9%
Granzyme B
9%